Spark and ADHD
The Center for Family Medicine published a research article about the comparison of the neuropsychological effects of Methylphenidate and Spark on children with attention-deficit hyperactivity disorder.
Methylphenidate is the most commonly prescribed psychostimulant and is indicated in the treatment of attention-deficit hyperactivity disorder and narcolepsy. In North America it is most commonly known as the brand name Ritalin.
The research article can be read here.